These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 27110300)

  • 1. The detective, prognostic, and predictive value of DNA methylation in human esophageal squamous cell carcinoma.
    Ma K; Cao B; Guo M
    Clin Epigenetics; 2016; 8():43. PubMed ID: 27110300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic CpG methylation biomarkers identified by methylation array in esophageal squamous cell carcinoma patients.
    Kuo IY; Chang JM; Jiang SS; Chen CH; Chang IS; Sheu BS; Lu PJ; Chang WL; Lai WW; Wang YC
    Int J Med Sci; 2014; 11(8):779-87. PubMed ID: 24936140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated analysis of DNA methylation and mutations in esophageal squamous cell carcinoma.
    Kishino T; Niwa T; Yamashita S; Takahashi T; Nakazato H; Nakajima T; Igaki H; Tachimori Y; Suzuki Y; Ushijima T
    Mol Carcinog; 2016 Dec; 55(12):2077-2088. PubMed ID: 26756304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a DNA methylome profile of esophageal squamous cell carcinoma and potential plasma epigenetic biomarkers for early diagnosis.
    Li X; Zhou F; Jiang C; Wang Y; Lu Y; Yang F; Wang N; Yang H; Zheng Y; Zhang J
    PLoS One; 2014; 9(7):e103162. PubMed ID: 25050929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide screening of DNA methylation associated with lymph node metastasis in esophageal squamous cell carcinoma.
    Nagata H; Kozaki KI; Muramatsu T; Hiramoto H; Tanimoto K; Fujiwara N; Imoto S; Ichikawa D; Otsuji E; Miyano S; Kawano T; Inazawa J
    Oncotarget; 2017 Jun; 8(23):37740-37750. PubMed ID: 28465481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTEN hypermethylation profiles of Chinese Kazakh patients with esophageal squamous cell carcinoma.
    Pan QF; Li WT; Dong HC; Chen YZ; Yin L; Liu W; Wang WW; Liu D; Li SG; Gu WY; Chen JZ; Yang L; Zhang WJ; Li F
    Dis Esophagus; 2014; 27(4):396-402. PubMed ID: 23980519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant methylation of different DNA repair genes demonstrates distinct prognostic value for esophageal cancer.
    Ling ZQ; Li P; Ge MH; Hu FJ; Fang XH; Dong ZM; Mao WM
    Dig Dis Sci; 2011 Oct; 56(10):2992-3004. PubMed ID: 21674174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promoter methylation of tumor suppressor genes in esophageal squamous cell carcinoma.
    Li JS; Ying JM; Wang XW; Wang ZH; Tao Q; Li LL
    Chin J Cancer; 2013 Jan; 32(1):3-11. PubMed ID: 22572016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic inactivation of secreted frizzled-related protein 2 in esophageal squamous cell carcinoma.
    Hao XW; Zhu ST; He YL; Li P; Wang YJ; Zhang ST
    World J Gastroenterol; 2012 Feb; 18(6):532-40. PubMed ID: 22363119
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Gonzaga IM; Soares Lima SC; Nicolau MC; Nicolau-Neto P; da Costa NM; de Almeida Simão T; Hernandez-Vargas H; Herceg Z; Ribeiro Pinto LF
    Clin Epigenetics; 2017; 9():130. PubMed ID: 29296124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkers.
    Lima SC; Hernández-Vargas H; Simão T; Durand G; Kruel CD; Le Calvez-Kelm F; Ribeiro Pinto LF; Herceg Z
    Epigenetics; 2011 Oct; 6(10):1217-27. PubMed ID: 21946330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network-based analysis identifies epigenetic biomarkers of esophageal squamous cell carcinoma progression.
    Cheng CP; Kuo IY; Alakus H; Frazer KA; Harismendy O; Wang YC; Tseng VS
    Bioinformatics; 2014 Nov; 30(21):3054-61. PubMed ID: 25015989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation-mediated repression of potential tumor suppressor miR-203a and miR-203b contributes to esophageal squamous cell carcinoma development.
    Liu Y; Dong Z; Liang J; Guo Y; Guo X; Shen S; Kuang G; Guo W
    Tumour Biol; 2016 Apr; 37(4):5621-32. PubMed ID: 26577858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p16, MGMT, RARbeta2, CLDN3, CRBP and MT1G gene methylation in esophageal squamous cell carcinoma and its precursor lesions.
    Roth MJ; Abnet CC; Hu N; Wang QH; Wei WQ; Green L; D'Alelio M; Qiao YL; Dawsey SM; Taylor PR; Woodson K
    Oncol Rep; 2006 Jun; 15(6):1591-7. PubMed ID: 16685400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant hypermethylation of RASSF2 in tumors and peripheral blood DNA as a biomarker for malignant progression and poor prognosis of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Cui J; Guo Y; Shen S; Guo X; Kuang G
    Clin Exp Metastasis; 2016 Jan; 33(1):73-85. PubMed ID: 26482475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma.
    Guo W; Dong Z; Shi Y; Liu S; Liang J; Guo Y; Guo X; Shen S; Shan B
    Dig Liver Dis; 2016 Aug; 48(8):961-9. PubMed ID: 27338851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relation to p53 mutations in esophageal squamous cell carcinoma.
    Zhang L; Lu W; Miao X; Xing D; Tan W; Lin D
    Carcinogenesis; 2003 Jun; 24(6):1039-44. PubMed ID: 12807758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequent methylation-associated silencing of a candidate tumor-suppressor, CRABP1, in esophageal squamous-cell carcinoma.
    Tanaka K; Imoto I; Inoue J; Kozaki K; Tsuda H; Shimada Y; Aiko S; Yoshizumi Y; Iwai T; Kawano T; Inazawa J
    Oncogene; 2007 Sep; 26(44):6456-68. PubMed ID: 17438526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel 19q13 KRAB zinc-finger tumour suppressor ZNF382 is frequently methylated in oesophageal squamous cell carcinoma and antagonises Wnt/β-catenin signalling.
    Zhang C; Xiang T; Li S; Ye L; Feng Y; Pei L; Li L; Wang X; Sun R; Ren G; Tao Q
    Cell Death Dis; 2018 May; 9(5):573. PubMed ID: 29760376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.